Real-time enrollment status for this advanced hr+/her2- breast cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:12 PM UTC
| NCT Number | NCT07604571 |
| Recruiting Status | Recruiting |
| Condition | Advanced HR+/HER2- Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 194 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 27, 2026 (Yesterday) |
As of August 28, 2026: Clinical trial NCT07604571 is currently recruiting participants. This phase1 study for advanced hr+/her2- breast cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07604571 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07604571 was last updated Yesterday (August 27, 2026). HelloStudys verifies this status automatically.